Telephone: 212.931.0704

In re Solodyn Antitrust Litigation, 14-md-2503-DJC (D. Mass.)

We represent plaintiffs and direct purchasers of Solodyn in this class action alleging that the seller of brand Solodyn engaged in a multi-part anticompetitive scheme, and conspired with manufacturers of generic versions of Solodyn to illegally delay generic competition for that drug.  Plaintiffs allege that the scheme included the brand manufacturer filing sham patent infringement lawsuits against manufacturers of generic versions of Solodyn, seeking to enforce an invalid and unenforceable patent, and then settling those infringement suits with illegal “reverse payment” agreements to delay generic competition.  We are seeking to recover overcharges on behalf of a class of direct purchasers under the federal antitrust laws.

Reach Out

Taus, Cebulash & Landau, LLP • 80 Maiden Lane • Suite 1204 • New York, NY 10038 • T: 212.931.0704 • E: